Supervised Psychedelic-AssistedTherapy in End-of-Life Care
Clinical research demonstrates that supervised psychedelic-assisted therapy may decrease depression and anxiety in some patients suffering from life-threatening illnesses and may relieve distress.1
To promote quality end-of-life care and provide peace of mind at the end of life, Compassion & Choices supports ongoing research related to supervised psychedelic-assisted therapy.